期刊文献+

5-脂氧合酶激活蛋白基因SG13S32位点多态性与维吾尔族缺血性脑卒中发病的相关性研究 被引量:4

Relationship between SG13S32 locus polymorphisms of 5-lipoxygenase-activating gene and ischemic stroke in Xinjiang Uygur
原文传递
导出
摘要 目的探讨5-脂氧合酶激活蛋白(ALOX5AP)基因多态性与新疆维吾尔族人群缺血性脑卒中发病的关系。方法选择自2011年10月至2012年10月就诊于新疆地区各三甲医院神经内科并确诊为急性缺血性脑卒中的当地长住维吾尔族患者197例(病例组)与同期体检的健康维吾尔族人群200例(对照组)为研究对象,应用聚合酶链反应-限制性片段长度多态性技术检测ALOX5AP基因SG13S32位点多态性.采用病例-对照设计统计分析基因型分布和等位基因频率的差异。结果ALOX5AP基因SG13S32位点的AC基因型在病例组与对照组间分布差异有统计学意义(P〈0.05),能显著提高缺血性脑卒中的发病风险(OR=5.27,95%CI:2.75-11.73)。病例组男女患者间各基因型分布差异无统计学意义(P〉0.05)。病例组不同TOAST分型中基因型分布差异无统计学意义(P〉0.05)。结论ALOX5AP基因SG13S32位点的AC基因型可增加维吾尔族缺血性脑卒中的发病风险,但与性别、TOAST分型无相关性。 Objective To investigate the relationship of the 5-1ipoxygenase-activating (ALOX5AP) gene polymorphisms with ischemic stroke in Uygur Xinjiang. Methods One hundred and ninety-seven Uygur patients with ischemic stroke and 200 Uygur healthy controls in Xinjiang were collected in our study from October 2011 to October 2012. The SG13S32 locus polymorphisms of A LOX5A P gene were determined by using PCR-restriction fragment length polymorphism technique. The case-control analysis was used to analyze the genotypes distributions and allele frequencies. Results There were statistical differences in the distributions of AC genotypes of SG13S32 locus in ALOX5AP gene between patient group and control group (P〈0.05) and AC genotypes of SG13S32 locus in ALOX5AP gene significantly increased the risk of ischemic stroke (OR=5.27, 95%CI: 2.75-11.73). The distributions of all genotypes showed no statistical differences between male and female in the patient group (P〉0.05). The distributions of all genotypes showed no statistical differences between patients of different TOAST ratio (P〉0.05). Conclusion The ALOX5AP gene SG13S32 locus polymorphisms are associated with risk of ischemic stroke in Xinjiang Uygur population; risk of ischemic stroke does not associate with gender and TOAST ratio.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2014年第12期1239-1242,共4页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(81060097)
关键词 5-脂氧合酶激活蛋白 单核苷酸多态性 缺血性脑卒中 维吾尔族 5-1ipoxygenase-activating gene Single-nucleotide polymorphism Ischemic stroke Uygur
  • 相关文献

参考文献16

  • 1Gretarsdottir S,Thorleifsson G,Reynisdottir ST,et al.The gene encoding phosphodiesterase 4D confers risk of ischemic stroke[J].Nat Genet,2003,35(2):131-138.
  • 2Helgadottir A,Manolescu A,Thorleifsson G,et al.The gene encoding 5-1ipoxygenase activating protein confers risk of myocardial infarction and stroke[J].Nat Genet,2004,36 (3):233-239.
  • 3Zee RY,Cheng S,Hegener HH,et al.Genetic variants of arachidonate 5-1ipoxygenase-activating protein,and risk of incident myocardial infarction and ischemic stroke:a nested case-control approach[J].Stroke,2006,37(8):2007-2011.
  • 4冀瑞俊,贾建平.ALOX5AP基因启动子区单核苷酸多态性与中国北方汉族人群缺血性卒中的关系[J].中华神经科杂志,2007,40(9):600-604. 被引量:6
  • 5Kaushal R,Pal P,Alwell K,et al.Association of ALOX5AP with ischemic stroke:a population-based case-control study[J].Hum Genet,2007,121(5):601-607.
  • 6Helgadottir A,Gretarsdottir S,St Clarir D,et al.Association between the gene encoding 5-1ipoxygenase-activating protein and stroke replicated in a Scottish population[J].Am J Hum Genet,2005,76(3):505-509.
  • 7Lee JD,Lee TH,Huang YC,et al.ALOX5AP genetic variants and risk of atherothrombotic stroke in the Taiwan Residents population[J].J Clin Neurosci,2011,18(12):1634-1638.
  • 8Zintzaras E,Rodopoulou P,Sakellaridis N.Variants of the Arachidonate 5-Lipoxygenase-Activating Protein(ALOX5AP)gene And risk of stroke:a HuGE gene-disease association review and meta analysis[J].Am J Epidemiol,2009,169(5):523-532.
  • 9河野茂胜,武玉欣.炎症性递质(白三烯、TXA_2、tachykinin等)与支气管哮喘[J].日本医学介绍,2002,23(3):99-103. 被引量:2
  • 10曹仁存,郑彩梅,欧阳尧.反复性脑缺血大脑皮质LTC_4、cAMP和OFR的代谢变化[J].脑与神经疾病杂志,2001,9(2):68-70. 被引量:2

二级参考文献82

  • 1曹仁存,郑彩梅.自由基与兴奋性氨基酸在反复性脑缺血神经元损伤中的作用[J].解放军医学杂志,1995,20(2):92-94. 被引量:4
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 3蔡乐,毕卫红,万崇华,黄文学,李健梅,杨锐.昆明市石林县脑卒中疾病负担分析[J].中国公共卫生,2007,23(1):45-46. 被引量:6
  • 4Brezinski DA, Nesto RW, Se rhan CN. Angioplasty triggers intracoronary leukotrienes and lipoxinA4 impact of aspirintherapy[J]. Circulation, 1992, 86(1 ) : 56 -63.
  • 5Dixon RA, Diehl RE, Opas E, et al. Requirement of a 5 - lipoxygenase activating protein for leukotriene synthesis [ J ]. Nature, 1990, 343(6255) : 282 -284.
  • 6Caterina RD, Zam polli A. From asthma to atherosclerosis -5 - lipoxygenase, leukotrienes, and inflammation [ J ]. N Engl J Med,2004, 350(1) : 4 -7.
  • 7Blake G J, Ridker PM. High sensitivity C - reactive protein for protein for predicting cardiovascular diseades:an inflammatory hypothesis[J]. Eur Heat J, 2001,22(5) : 349 -352.
  • 8Funk CD. Leukotriene modifiers as potential therapeutics for cardiovascular disease[J]. Nat Rev Drug Discov, 2005, 4(8): 664 - 672.
  • 9Helgadottir A, Gretarsdouir S, St Clair D, et al. Association between the gene encoding 5 - lipoxygenase - activating protein and stroke replicated in a scottish population [ J ]. Am J Hum Genet, 2005, 76 (3) : 505 - 509.
  • 10Lohmussaar E, Gschwendtner A, Mueller J C, et al. ALOXSAP gene and the PDFAD gene in a central European population of stroke patients[J]. Stroke, 2005, 36(4) : 731 -734.

共引文献8

同被引文献48

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部